Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Tonix Pharm Hldg (TNXP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,952
  • Shares Outstanding, K 1,529
  • Annual Sales, $ 0 K
  • Annual Income, $ -21,120 K
  • 36-Month Beta 1.71
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.16

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -3.87
  • Number of Estimates 2
  • High Estimate -3.84
  • Low Estimate -3.90
  • Prior Year -6.70
  • Growth Rate Est. (year over year) +42.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.70 +13.53%
on 12/24/18
2.50 -22.80%
on 01/15/19
-0.13 (-6.31%)
since 12/21/18
3-Month
1.70 +13.53%
on 12/24/18
9.90 -80.51%
on 10/31/18
-4.77 (-71.19%)
since 10/22/18
52-Week
1.70 +13.53%
on 12/24/18
51.10 -96.22%
on 06/07/18
-38.47 (-95.22%)
since 01/22/18

Most Recent Stories

More News
Tonix Pharmaceuticals to Present at Upcoming Investor Conferences and Participate in Featured Panel Discussion

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present a company overview at two...

TNXP : 1.93 (-6.31%)
Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat serious neuropsychiatric conditions...

TNXP : 1.93 (-6.31%)
Tonix Pharmaceuticals Announces Closing of $15,000,000 Public Offering

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat serious neuropsychiatric conditions...

TNXP : 1.93 (-6.31%)
PIMCO Closed-End Funds Declare Special Year-End Distribution

The Board of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds") has declared a special year-end distribution for certain Fund's common shares as summarized...

IPG : 21.65 (-2.70%)
NGVC : 15.75 (-2.42%)
STC : 43.17 (-0.99%)
ATUS : 18.73 (-1.78%)
RBA : 36.28 (+0.08%)
MHK : 126.72 (+0.08%)
NVCR : 46.62 (+0.37%)
CVSI : 4.6600 (+6.39%)
AC : 39.07 (-3.82%)
BSX : 37.26 (-1.14%)
HON : 139.82 (-1.43%)
POTND : 0.0200 (+32.45%)
PRTT : 1.2500 (-30.56%)
TARSD : 0.2033 (-1.64%)
NKE : 80.75 (+0.37%)
ROIC : 16.78 (-0.59%)
DGX : 86.18 (-0.99%)
EIX : 54.21 (-1.22%)
GARLF : 0.0850 (-2.19%)
MRNA : 15.56 (-6.77%)
MSPC : 0.0002 (unch)
RYAAY : 69.09 (+5.08%)
BA : 357.90 (-1.87%)
BDC : 50.92 (-3.69%)
BC : 48.99 (-2.68%)
OXFD : 14.46 (-2.82%)
NDAQ : 83.40 (+0.31%)
TTOO : 3.60 (-0.28%)
DMAC : 3.60 (-1.10%)
CMCM : 6.50 (-0.76%)
ALGN : 216.16 (-1.79%)
ABM : 35.23 (-2.08%)
RTN : 163.71 (-1.03%)
IESC : 17.02 (+0.71%)
KIDS : 34.06 (+0.06%)
CYL.VN : 0.175 (+12.90%)
FLIR : 44.73 (-1.45%)
NETC.CN : 0.140 (+7.69%)
SLCA : 13.36 (-3.95%)
BANX : 19.85 (+0.61%)
APOG : 33.82 (-1.26%)
RBBN : 5.53 (-2.47%)
SPLIF : 0.2100 (-0.43%)
SO : 47.07 (-0.32%)
SNWV : 0.2170 (-9.01%)
ACB : 6.19 (-3.88%)
CE : 95.73 (-2.13%)
QILFF : 0.1900 (-4.62%)
QILFD : 0.2331 (-29.98%)
MANH : 47.82 (-1.14%)
MKL : 1,035.00 (-3.11%)
HAL : 31.26 (-3.07%)
LZB : 29.68 (-1.49%)
INTC : 48.27 (-1.87%)
APHQF : 11.5700 (-3.05%)
AMZN : 1,632.17 (-3.77%)
ACHC : 28.32 (-2.31%)
TX : 28.26 (-2.18%)
SRPT : 120.28 (-2.05%)
JOUT : 63.52 (-4.95%)
CCAN : 0.2650 (+10.42%)
OBMP : 0.0103 (-6.36%)
ELY : 16.51 (-2.77%)
DY : 57.47 (-3.14%)
HIPH : 0.0530 (-5.19%)
POTN : 0.1058 (-0.94%)
JWN : 47.07 (-0.95%)
SYF : 26.55 (+1.03%)
AQUA : 10.04 (-4.02%)
NWVCF : 1.0517 (+0.16%)
USYNF : 3.1500 (+5.77%)
EMR : 63.01 (-1.05%)
BXE : 0.43 (-2.27%)
HSY : 108.31 (+0.16%)
EW : 168.29 (-0.07%)
SCQBD : 0.7420 (+1.08%)
PTS.TO : 13.11 (+0.15%)
PSX : 93.00 (-2.41%)
MVIS : 0.79 (-1.86%)
PCI : 22.27 (-1.63%)
PCN : 15.42 (+0.72%)
AVT : 41.25 (-2.92%)
MGNX : 11.53 (-6.34%)
ICBK : 18.21 (-4.26%)
DLR : 105.10 (-2.00%)
RHI : 59.76 (-1.82%)
YVR : 2.37 (-1.66%)
PTY : 16.08 (+0.63%)
PDI : 31.12 (-1.27%)
TNXP : 1.93 (-6.31%)
GBT : 47.82 (-2.15%)
QI.VN : 0.290 (-27.50%)
TSRO : 74.96 (+0.03%)
RHP : 76.42 (-0.31%)
NKTR : 44.76 (-3.12%)
GOOG : 1,070.52 (-2.53%)
JBLU : 17.37 (-1.31%)
IGC : 2.49 (unch)
WBT : 13.21 (-0.53%)
WRY.VN : 0.045 (+800.00%)
SAPIF : 28.6410 (-1.69%)
WSO : 144.38 (-0.99%)
LMT : 279.59 (-1.16%)
CMCSA : 34.97 (-3.42%)
HSDT : 7.65 (-8.16%)
GWRE : 84.94 (-0.90%)
CLGX : 36.05 (-1.39%)
FNSR : 21.21 (-2.35%)
SONS : 7.83 (+2.76%)
DEWM : 0.0010 (-9.09%)
SLG : 88.34 (-1.01%)
UPS : 102.68 (+1.06%)
PFN : 9.82 (+0.10%)
KMB : 115.23 (-1.40%)
ANZ.VN : 0.075 (+7.14%)
TAOP : 1.14 (-5.00%)
NSU : 4.48 (-0.88%)
CBDS : 3.5100 (+2.63%)
CTXS : 108.25 (-0.45%)
PCOM : 9.80 (-0.71%)
HTHT : 31.16 (-10.79%)
MAN : 73.13 (-1.76%)
CNK : 39.56 (-3.32%)
AMAT : 34.44 (-3.56%)
FMCC : 2.5100 (+5.46%)
MRK : 75.83 (-0.05%)
ATOS : 1.38 (+2.99%)
WTCRF : 0.0138 (unch)
MLRKF : 0.0835 (-6.07%)
GAZ-UN.VN : 0.600 (unch)
MEOH : 55.91 (-5.17%)
COOL : 17.33 (-0.69%)
SAVE : 58.06 (-2.19%)
PCRX : 40.46 (+1.05%)
RNLSY : 12.7650 (-1.47%)
COL : 141.04 (-0.42%)
COR : 93.21 (-1.15%)
IDXG : 1.03 (-4.63%)
MCD : 184.57 (+1.10%)
ETST : 0.8500 (+19.72%)
QNIIF : 0.7100 (-2.62%)
PII : 85.45 (-3.25%)
AMRS : 3.44 (-4.18%)
SON : 54.85 (+0.07%)
MCK : 125.87 (-0.63%)
APHA : 7.08 (+5.99%)
MCO : 155.48 (-2.46%)
GSKY : 11.00 (-0.09%)
LH : 135.70 (-1.45%)
SAP.TO : 38.67 (-1.60%)
ODFL : 132.90 (-2.73%)
NEU : 401.66 (+0.28%)
ORTX : 12.90 (-3.15%)
BXE.TO : 0.55 (-3.51%)
GWPRF : 11.8700 (+6.23%)
PZN : 8.49 (-3.41%)
RBX.VN : 0.075 (unch)
RNG : 88.78 (-2.71%)
SPG : 173.26 (-0.40%)
TRVN : 0.53 (-3.45%)
AMC : 13.51 (-6.57%)
UTX : 111.06 (-2.49%)
AMD : 19.76 (-4.86%)
NDLS : 7.45 (-1.46%)
MPWR : 120.98 (-3.04%)
KGKG : 0.0580 (+3.94%)
FRO-UN.VN : 0.550 (unch)
DMCAF : 0.2660 (-5.10%)
IRMTF : 11.9721 (-0.40%)
BOX : 19.45 (-2.16%)
IQST : 2.5000 (+25.00%)
ASPS : 23.23 (-2.72%)
HMNY : 0.01 (unch)
ROP : 274.70 (-2.60%)
GOVB : 14.5000 (unch)
PKO : 25.55 (-1.01%)
MYGN : 28.89 (-2.63%)
CRL : 117.59 (-1.36%)
GLPH : 0.0220 (-12.00%)
BXXRF : 0.0051 (-74.50%)
ADTN : 11.78 (-0.93%)
GRNH : 0.0200 (unch)
NS : 25.65 (-2.77%)
LTS : 2.99 (-3.55%)
INT : 23.97 (-1.36%)
INPX : 2.28 (+2.24%)
GSPT : 0.0600 (-50.00%)
MRO.VN : 0.110 (+10.00%)
COST : 212.40 (-0.56%)
EFX : 103.62 (-0.59%)
BMRN : 95.66 (-2.08%)
SPGI : 187.29 (-0.72%)
IGCC : 0.3940 (+3.41%)
PYPL : 89.94 (-1.29%)
LHSIF : 0.7526 (-0.97%)
TDY : 217.39 (-3.44%)
AZPN : 88.93 (-2.24%)
ENW.VN : 1.410 (+2.92%)
DMA.VN : 4.630 (-2.11%)
SNAP : 5.93 (-4.05%)
KSU : 108.45 (-1.87%)
MERC : 14.61 (-1.08%)
DVA : 56.85 (-0.91%)
UNI.VN : 3.700 (-0.27%)
MGI : 2.21 (+0.45%)
IGAP : 0.2310 (-57.92%)
FIT : 6.06 (+0.17%)
RAD : 0.94 (-3.51%)
LDSR : 0.0042 (+7.69%)
CYLYF : 0.1108 (+14.23%)
PMX : 11.38 (-1.04%)
ROBXF : 0.1851 (+262.94%)
BRO : 28.32 (-1.12%)
Tonix Pharmaceuticals Prepares for Phase III Trial for Tonmya, Analysts Review and Target

NEW YORK, NY / ACCESSWIRE / December 3, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive...

TNXP : 1.93 (-6.31%)
Tonix Pharmaceuticals Announces Additional Details of the New Phase 3 Study of Tonmya(R) for PTSD, Following Receipt of FDA Minutes

New Phase 3 RECOVERY Trial to Include Approximately 250 Participants

TNXP : 1.93 (-6.31%)
Tonix Pharmaceuticals Announces 1-for-10 Reverse Stock Split

Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat serious neuropsychiatric conditions and biological...

TNXP : 1.93 (-6.31%)
Analysis: Positioning to Benefit within The ONE Group Hospitality, Biofrontera AG Sponsored ADR, Aridis Pharmaceuticals, Universal Logistics, Tonix Pharmaceuticals Holding, and AVROBIO -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The ONE Group Hospitality,...

ULH : 20.33 (-1.83%)
TNXP : 1.93 (-6.31%)
BFRA : 13.29 (-2.35%)
AVRO : 13.50 (+1.05%)
ARDS : 8.72 (-3.22%)
STKS : 3.20 (+1.59%)
Tonix: 3Q Earnings Snapshot

NEW YORK (AP) _ Tonix Pharmaceuticals Holding Corp. (TNXP) on Friday reported a loss of $5.5 million in its third quarter.

TNXP : 1.93 (-6.31%)
Tonix Pharmaceuticals Reports Third Quarter 2018 Financial Results and Operational Highlights

New Phase 3 Trial of Tonmya(R) for the Treatment of PTSD to Commence First Quarter 2019

TNXP : 1.93 (-6.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade TNXP with:

Business Summary

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102,...

See More

Key Turning Points

2nd Resistance Point 2.15
1st Resistance Point 2.04
Last Price 1.93
1st Support Level 1.87
2nd Support Level 1.81

See More

52-Week High 51.10
Fibonacci 61.8% 32.23
Fibonacci 50% 26.40
Fibonacci 38.2% 20.57
Last Price 1.93
52-Week Low 1.70

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar